Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG.
Ahmad JaliliPiergiacomo Calzavara-PintonL KircikD Lons-DanicAndrew E PinkS TyringPablo de la Cueva-DobaoMelinda J GooderhamSiegfried SegaertN NyholmH ThoningB PetersenD ThaçiPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2021)
Cal/BD foam significantly improved DLQI, EQ-5D-5L-PSO and PSI scores during the open-label and maintenance phases. Patients assigned to proactive management had significantly better DLQI and PSI scores and numerically better EQ-5D-5L-PSO versus reactive management. Additionally, baseline flare was associated with worse PROs than the start of a relapse, and patients starting a relapse also had worse PROs than patients in remission.